- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4188 - 1,3-Diazoles condensed with heterocyclic ring systems, e.g. biotin, sorbinil
Patent holdings for IPC class A61K 31/4188
Total number of patents in this class: 1808
10-year publication summary
|
132
|
130
|
144
|
161
|
116
|
127
|
121
|
121
|
116
|
86
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2062 |
38 |
| University of Southern California | 2122 |
29 |
| Boehringer Ingelheim International GmbH | 4644 |
24 |
| Novartis AG | 10707 |
23 |
| Achillion Pharmaceuticals, Inc. | 164 |
23 |
| Genentech, Inc. | 4012 |
18 |
| The Johns Hopkins University | 5730 |
18 |
| Merck Sharp & Dohme LLC | 3737 |
18 |
| DSM IP Assets B.V. | 5572 |
17 |
| Janssen Pharmaceutica N.V. | 3367 |
16 |
| F. Hoffmann-La Roche AG | 7946 |
15 |
| Bristol-myers Squibb Company | 4840 |
14 |
| Société des Produits Nestlé S.A. | 9329 |
12 |
| Takeda Pharmaceutical Company Limited | 2704 |
12 |
| AstraZeneca AB | 2872 |
11 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 309 |
11 |
| Shanghai Hansoh Biomedical Co., Ltd. | 273 |
11 |
| Gilead Pharmasset LLC | 41 |
10 |
| Neurophyxia B.V. | 12 |
10 |
| The Regents of the University of California | 20153 |
9 |
| Other owners | 1469 |